ArticleAmerican journal of hematology2025

Clinical significance of complete remission and measurable residual disease in relapsed/refractory multiple myeloma patients treated with T-cell redirecting immunotherapy.

Aintzane Zabaleta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.